ArticleBMC psychiatry2022
Detecting subtle signs of depression with automated speech analysis in a non-clinical sample.
Article in BMC psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Performance of Automatic Speech Analysis in Detecting Depression: Systematic Review and Meta-Analysis.JMIR mental health · 2025Pooled it
- Curiosity in a Novel Virtual Reality Scenario and Its Association With Symptoms of Depression: Observational Pilot Investigation.JMIR formative research · 2026Observational
- A Conversational Platform (Okaya) for Multimodal Digital Biomarkers of Fatigue, Cognition, and Mental Health: Feasibility Observational Study.JMIR formative research · 2026Observational
- When a chatbot asks "How are you?": A cross-sectional study of AI call conversations and depressive symptom detection among older adults in rural South Korea.BMC geriatrics · 2026Article
- Low-burden speech-based screening of depressive symptoms using ultra-short speech samples.Frontiers in psychiatry · 2026Article
- Exploring Acoustic Correlates of Depression and Preliminary Screening Models Using XGBoost and SHAP.Behavioral sciences (Basel, Switzerland) · 2025Article
- Integration of Multi-Modal Biosensing Approaches for Depression: Current Status, Challenges, and Future Perspectives.Sensors (Basel, Switzerland) · 2025Review
- Major depressive disorder recognition based on electronic handwriting recorded in psychological tasks.BMC medicine · 2025Article
- [Construction of recognition models for subthreshold depression based on multiple machine learning algorithms and vocal emotional characteristics].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025Article
- The association between speech impairments and depression in Chinese adults aged 45 and older: insights from the CHARLS database.BMC psychiatry · 2025Article
- Sex differences in PTSD speech biomarkers assessed by virtual agent-induced conversations.Frontiers in psychology · 2025Article
- Uncovering unseen ties: a network analysis explores activities of daily living limitations and depression among Chinese older adults.Frontiers in aging neuroscience · 2025Article
- The voice of depression: speech features as biomarkers for major depressive disorder.BMC psychiatry · 2024Article
- Automated Speech Analysis for Risk Detection of Depression, Anxiety, Insomnia, and Fatigue: Algorithm Development and Validation Study.Journal of medical Internet research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutomated speech analysis has gained increasing attention to help diagnosing depression. Most previous studies, however, focused on comparing speech in patients with major depressive disorder to that in healthy volunteers. An alternative may be to associate speech with depressive symptoms in a non-clinical sample as this may help to find early and sensitive markers in those at risk of depression.
methodsWe included n = 118 healthy young adults (mean age: 23.5 ± 3.7 years; 77% women) and asked them to talk about a positive and a negative event in their life. Then, we assessed the level of depressive symptoms with a self-report questionnaire, with scores ranging from 0-60. We transcribed speech data and extracted acoustic as well as linguistic features. Then, we tested whether individuals below or above the cut-off of clinically relevant depressive symptoms differed in speech features. Next, we predicted whether someone would be below or above that cut-off as well as the individual scores on the depression questionnaire. Since depression is associated with cognitive slowing or attentional deficits, we finally correlated depression scores with performance in the Trail Making Test.
resultsIn our sample, n = 93 individuals scored below and n = 25 scored above cut-off for clinically relevant depressive symptoms. Most speech features did not differ significantly between both groups, but individuals above cut-off spoke more than those below that cut-off in the positive and the negative story. In addition, higher depression scores in that group were associated with slower completion time of the Trail Making Test. We were able to predict with 93% accuracy who would be below or above cut-off. In addition, we were able to predict the individual depression scores with low mean absolute error (3.90), with best performance achieved by a support vector machine.
conclusionsOur results indicate that even in a sample without a clinical diagnosis of depression, changes in speech relate to higher depression scores. This should be investigated in more detail in the future. In a longitudinal study, it may be tested whether speech features found in our study represent early and sensitive markers for subsequent depression in individuals at risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.